Unmatched Recruitment and Retention Metrics
AGA Clinical Trials is known throughout Southeast Florida as a highly-awarded clinical trial research site. Having conducted over 200 trials in different phases, AGA has access to a highly diverse pediatric and adult population, as well as healthy subject profiles. With a strong focus on patient retention, AGA has enrolled more than 13,000 participants and is a trusted and reliable healthcare partner in the Miami community. AGA can readily help you safely explore the clinical pharmacology of new compounds with a wide range of on-site diagnostic and medical services.
In 2023, AGA Clinical Trials was the first US site to receive certification by GCSA – The Global Clinical Site Assessment Standard. AGA was then the first site in the world to receive triple certification with additional individual accreditation from IAOCR – The International Organization for Clinical Research for both Dr. Maria Ximena Graber, CEO, and Dr. Roberto Aguirre, President.
The distinctive IAOCR and GCSA certification marks provide reassurance to patients and sponsors that the sites, and the people working within them, have undergone rigorous quality assurance assessment and are working to trusted, world-class standards.
AGA Clinical Trials Patient Population in Miami
Specialty Capabilities:
- On-Site Fibroscan Testing
- Imaging Studies (PET, DEXA, PDFF MRI)
- Cognitive Testing
- CSF Collection
- PMBC Processing/Collection
- Multiple Organ Biopsies
- Liver Biopsy
- STAT Labs for Hematology and Chemistry
- Telemetry
Phase I Capabilities:
- Multispecialty CRU with 12 Beds
- 11,000 Sqft Boutique Research Facility
- Level 3 Hospitals Nearby
- Healthy Volunteers
- Special Populations
- FIH
- PK/PD
- SAD/MAD
- Toxicology
- Food Effect
- DDI
- Biologics/Biosimilars
- Vaccine Studies in Pediatric and Adult Populations
